Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(10.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)
Lexeo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(10.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)
Lexeo Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Janus Henderson Group plc(10.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)